Clinical trial
MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal…
NCT00099346 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00099346 |
|---|---|
| Title | MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) |
| Official title | A Phase I/IIa Study Evaluating the Safety/Tolerability, Pharmacokinetics, and Efficacy of MK0457 Administered as a 5-Day Continuous Infusion in Patients With Advanced Colorectal Cancer and Other Solid Tumors |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Advanced Solid Tumors |
| Intervention type | Drug |
| Interventions | MK0457, VX-680 (Aurora Kinase Inhibitor) |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Dec 13, 2004 |
| Last update posted | Jun 17, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: